Execs On The Move: Top Execs Take Helm At Medtech Firms; Internal Shuffling At Intricon And Structo
MiMedx chief strategy officer and Honeywell chief financial officer head to Micron Medical and Structo as CEOs; Intricon CFO promoted to CEO; Structo CEO changes role to head R&D; and more.
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.